Seroatlas · Human Serome Atlas

RNASEH2A

Ribonuclease H2 subunit A

Also known as: AGS4, RNASEHI, RNH2A_HUMAN, RNHIA, RNHL

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O75792
Gene
RNASEH2A
Ensembl
ENSG00000104889
Chromosome
19
Canonical length
299 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Cytosol

OverviewNCBI Gene

The protein encoded by this gene is a component of the heterotrimeric type II ribonuclease H enzyme (RNAseH2). RNAseH2 is the major source of ribonuclease H activity in mammalian cells and endonucleolytically cleaves ribonucleotides. It is predicted to remove Okazaki fragment RNA primers during lagging strand DNA synthesis and to excise single ribonucleotides from DNA-DNA duplexes. Mutations in this gene cause Aicardi-Goutieres Syndrome (AGS), a an autosomal recessive neurological disorder characterized by progressive microcephaly and psychomotor retardation, intracranial calcifications, elevated levels of interferon-alpha and white blood cells in the cerebrospinal fluid.[provided by RefSeq, Aug 2009]

Canonical amino-acid sequenceUniProt

299 residues, UniProt reviewed canonical sequence.

>O75792|RNASEH2A
     1  MDLSELERDN TGRCRLSSPV PAVCRKEPCV LGVDEAGRGP VLGPMVYAIC YCPLPRLADL
    61  EALKVADSKT LLESERERLF AKMEDTDFVG WALDVLSPNL ISTSMLGRVK YNLNSLSHDT
   121  ATGLIQYALD QGVNVTQVFV DTVGMPETYQ ARLQQSFPGI EVTVKAKADA LYPVVSAASI
   181  CAKVARDQAV KKWQFVEKLQ DLDTDYGSGY PNDPKTKAWL KEHVEPVFGF PQFVRFSWRT
   241  AQTILEKEAE DVIWEDSASE NQEGLRKITS YFLNEGSQAR PRSSHRYFLE RGLESATSL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against RNASEH2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.31
Highest tissue expression
26 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 26 nTPM
  • thymus: 23 nTPM
  • tonsil: 18 nTPM
  • esophagus: 17 nTPM
  • lymph node: 16 nTPM
  • testis: 14 nTPM

Single-cell type

  • enteric transient amplifying cells: 17 nCPM
  • megakaryocytes: 12 nCPM
  • extravillous trophoblasts: 12 nCPM
  • paneth cells: 12 nCPM
  • migrating cytotrophoblasts: 9.3 nCPM
  • enteric stem cells: 8.7 nCPM

Immune cell

  • NK-cell: 45 nTPM
  • memory B-cell: 37 nTPM
  • naive B-cell: 36 nTPM
  • non-classical monocyte: 28 nTPM
  • intermediate monocyte: 28 nTPM
  • T-reg: 26 nTPM

Brain region

  • white matter: 18 nTPM
  • cerebellum: 18 nTPM
  • medulla oblongata: 15 nTPM
  • pons: 14 nTPM
  • basal ganglia: 14 nTPM
  • cerebral cortex: 14 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about RNASEH2A.

Disease | AllUniProt

Conditions RNASEH2A is implicated in, by any mechanism.

Disease | GeneticClinVar

44 pathogenic / likely-pathogenic of 563 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.88
gnomAD pLI
0
gnomAD missense Z
0.19
DepMap mean gene effect
-0.23
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of RNASEH2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads RNASEH2A as an antibody target. Whether an autoantibody or antibody against RNASEH2A could matter depends on whether native RNASEH2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

RNASEH2A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label RNASEH2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/RNASEH2A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...